Xeris Biopharma Holdings, Inc. Stock Forecast

Xeris Biopharma Holdings, Inc. stock upgraded to Buy Candidate.
(Updated on Jun 19, 2024)

0A8E.L Signals & Forecast

The Xeris Biopharma Holdings, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately £2.21. On a fall, the stock will find some support from the long-term average at approximately £2.05. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, June 18, 2024, and so far it has risen 1.26%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Xeris Biopharma Holdings, Inc. stock

Xeris Biopharma Holdings, Inc. finds support from accumulated volume at £2.08 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved £0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0.95%

Our recommended stop-loss: £2.05 (-5.01%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (0A8E.L) For The Upcoming Trading Day Of Thursday 20th

For the upcoming trading day on Thursday, 20th we expect Xeris Biopharma Holdings, Inc. to open at £2.16, and during the day (based on 14 day Average True Range), to move between £2.07 and £2.25, which gives a possible trading interval of +/-£0.0871 (+/-4.03%) up or down from last closing price. If Xeris Biopharma Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 8.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at £2.20 (1.76%) than the support at £2.08 (3.79%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Xeris Biopharma Holdings, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Xeris Biopharma Holdings, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.817 Buy Candidate Upgraded

Predicted Opening Price for Xeris Biopharma Holdings, Inc. of Thursday, June 20, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.